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Introduction
The presence of blood flow between the aorta and atrium 
is a rare but complex pathological condition, also known as 
aorto-atrial fistula (AAF). Systemic symptoms such as heart 
failure, weakness and oedema may occur as well as more 
local symptoms including dyspnoea, chest pain, palpitations, 
and fatigue or coughing.
The exact incidence of AAF is currently unknown and 
there are many gaps in our knowledge regarding various 
aspects of AAF, such as diagnosis strategies and management 
options. The aim of the present study was to systematically 
review the available case report literature reporting AAF. 
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These data will provide an overview of the demographic 
characteristics of AAF, the pre-operative imaging techniques 
used to diagnose AAF, the anatomy and causes of AAF and 
finally give some information on the therapeutic options for 
AAF and the respective outcomes. These data should enable 
surgeons to prevent this condition occurring initially, as 
well as treating it optimally when it does occur.
Evidence acquisition 
We systematically reviewed literature on AAF formation 
and closure. Separate Medline (PubMed), EMBASE, and 
Cochrane database queries were performed. The following 
MESH headings were used: atrium, ventricle, fistula, 
cardiac, shunts, aortic, aorto-atrial tunnels and coronary 
cameral fistula. All papers were considered for analysis 
irrespective of their quality, or the journal in which they 
were published. Strict criteria and screening of titles and 
abstracts were used to select relevant papers. All papers 
and reports on AAF formation and closure were included. 
Reports not written in English were excluded, as well as 
reports without a clear description of AAF or AAF closure. 
No randomized controlled trials or clinical studies were 
identified. We evaluated the remaining case reports. We 
identified 132 case reports with a total of 136 patients for 
our analysis (Figure 1). In each of these reports we extracted 
the following information: year of publication, number of 
patients, age, sex, previous cardiac surgery, time between 
surgery and AAF formation, fistula tract, presumed AAF 
cause, surgical technique for AAF closure, follow-up and 
outcome (Table 1). 
Evidence synthesis 
Demographics
7% of the studied articles were published in the period 
from 1960 till 1980. Around 70% of the articles were 
published after 2000 whilst approximately 35% were 
published after 2010 (Figure 2A). Most case reports on AAF 
were from the United States of America (39 cases) followed 
by the United Kingdom (12 cases). Most Asian publications 
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Figure 1 Schematic of Study Selection.
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Table 1 List of all analyzed articles
Reference
Year 
published
Sex/age 
(years)
Previous surgery
Time between 
surgery and 
AAF
Type of 
AAF
Cause of AAF
Closure 
technique
Follow-up/
outcome
RB Hsu 2000 M/67 None N/A AscAo-RA Endocarditis Surgical Lived
W Dewilde 2008 M/51 AVR + MVR 4 years AscAo-LA Prosthetic valve 
endocarditis
Conservative 
medical 
treatment
Lived
D Patsouras 2002 M/70 AVR 2x 7 years;  
1 month
AscAo-LA Aortic 
dissection
Conservative 
medical 
treatment
Died
CS Balestrini 2013 M/57 CABG 12 years AscAo-RA SVG aneurysm Percutaneous Lived
DA Chung 2000 M/52 Aortic root 
replacement + 
CABG 
17 years AscAo-RA Aortic 
dissection
Surgical Lived
F Haddad 2008 M/66 AVR + 
ascending aorta 
replacement
10 days AscAo-RA Aortic dissection 
(Giant cell 
arthritis)
Surgical Lived
SS Dhawan 2008 M/65 AVR 10 weeks AscAo-LA Prosthetic valve 
endocarditis
Patient 
refused 
surgery
Not 
described
TP Archer 1997 M/61 None N/A AscAo-LA Endocarditis Patient died 
before surgery
Died
BN Shah 2012 F/54 AVR 8 years AscAo-LA Complication of 
cardiac surgery
Surgical Not 
described
K Suzuki 2006 F/77 Aortic arch 
replacement
8 years AscAo-RA Complication of 
cardiac surgery
Surgical Lived
S Cheng Siang 1967 M/55 None N/A AscAo-LA Aneurysm Conservative 
medical 
treatment
Died
O Candan 2012 F/55 MVR 2x, mitral 
valve repair
4 years;  
3 years; 
1 month
AscAo-RA Prosthetic valve 
endocarditis
Surgical Died
Y Sakano 2007 F/70 Ascending aorta 
replacement
16 years AscAo-RA Complication of 
cardiac surgery
Surgical Lived
S Bouchez 2012 M/61 None N/A AscAo-LA Accidental 
finding
No procedure 
performed
Lived
K Ananthasubramaniam 2005 M/66 AVR 2x Not described;  
4 years
AscAo-LA Complication of 
cardiac surgery
Surgical Lived
PR Menon 2011 F/73 Mitral valve repair 
+ tricuspid valve 
repair
1 year AscAo-RA Complication of 
cardiac surgery
Surgical Lived
S Pagni 2013 F/69 CABG 8 years AscAo-RA Aortic 
dissection
Surgical Lived
R Estévez-Loureiro 2012 M/44 AVR 9 years AscAo-LA Prosthetic valve 
endocarditis
Percutaneous Not 
described
J Swampillai 2012 F/16 None N/A AscAo-RA Endocarditis Surgical Not 
described
Table 1 (continued)
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Table 1 (continued)
Reference
Year 
published
Sex/age 
(years)
Previous surgery
Time between 
surgery and 
AAF
Type of 
AAF
Cause of AAF
Closure 
technique
Follow-up/
outcome
R Dalla Pozza 2009 F/72 Aortic valve 
repair
<1 week AscAo-LA 
+ AscAo-
RA
Complication of 
cardiac surgery
Percutaneous Lived
MSL Sey 2010 M/20 Percutaneous 
closure of ASD
3 weeks AscAo-RA ASD device 
closure
Surgical Lived
Y Cho 2005 F/61 None N/A AscAo-LA Endocarditis Surgical Lived
M Sreedharan 2006 M/11 None N/A AscAo-RA Congenital Percutaneous Lived
N Ozer 2007 F/41 AVR 13 years AscAo-RA Prosthetic valve 
endocarditis
Patient died 
before surgery
Died
MM Stechert 2007 M/65 AVR 6 months AscAo-LA Prosthetic valve 
endocarditis
Surgical Lived
C Russo 2001 F/70 Ascending aorta 
replacement
6 years AscAo-RA Aortic 
dissection
Surgical Lived
A Melua 1998 M/30 None N/A AscAo-RA Behcet’s 
disease
Surgical Lived
WM Wilson 2010 M/17 Percutaneous 
closure of ASD
3 months AscAo-LA ASD device 
closure
Surgical Lived
A Kalra 2013 F/61 Myectomy for 
hypertrophic 
cardiomyopathy 
+ CABG
2 months AscAo-RA Aortic 
dissection
Surgical Not 
described
H Matsuhisa 2004 M/85 None N/A AscAo-RA Aortic 
dissection
Surgical Lived
VR Aligeti 2012 M/61 RFA 2x Not described AscAo-RA Complication of 
cardiac surgery
Surgical Lived
AF Elwatidy 2003 F/3 None N/A DescAo-
RA
Congenital Surgical Lived
A Alozie 2012 M/19 None N/A AscAo-RA Aneurysm Surgical Lived
MS Topcuoğlu 1997 M/20 None N/A AscAo-LA Congenital Surgical Lived
M Sehgal 2002 M/53 TIPS procedure, 
TIPS revision
4 years  
5 months;  
3 years  
11 months
AscAo-RA Stent protuding 
RA
Patient 
refused 
surgery
Died
AK Sarkar 2013 M/5 
months
None N/A DescAo-
LA
Congenital Patient 
refused 
surgery
Not 
described
D Patsouras 2009 M/84 AVR 18 years AscAo-LA Prosthetic valve 
endocarditis
Conservative 
medical 
treatment
Lived
MT Barrio-López 2012 M/56 Multiple 
implantations 
of endovascular 
prostheses in IVC
1 day AscAo-RA Stent protuding 
RA
Surgical Lived
Table 1 (continued)
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Table 1 (continued)
Reference
Year 
published
Sex/age 
(years)
Previous surgery
Time between 
surgery and 
AAF
Type of 
AAF
Cause of AAF
Closure 
technique
Follow-up/
outcome
M Chacko 2005 M/58 None N/A AscAo-LA Aneurysm Surgical Not 
described
S Moral 2009 F/27 AVR + Aortic root 
replacement
3 months AscAo-RA 
+ AscAo-
RV
Prosthetic valve 
endocarditis
Not described Not 
described
S Bartus 2008 M/53 Percutaneous 
closure of 
congenital ASD
18 months AscAo-RA ASD device 
closure
Spontaneous 
closure 
Lived
JM Hernández-García 2005 F/72 Resection left 
atrial myxoma 2x
18 years;  
15 years
AscAo-LA Complication of 
cardiac surgery
Percutaneous Lived
S Maffè 2012 M/69 AVR 8 years AscAo-RA Prosthetic valve 
endocarditis
Surgical Died
S Rubin 2006 M/30 None N/A AscAo-RA Trauma Surgical Lived
DK Millward 1972 M/32 None N/A AscAo-RA Aortic 
dissection
Patient died 
before surgery
Died
GY Jang 2005 F/54 Percutaneous 
closure of ASD
2 months AscAo-RA ASD device 
closure
Surgical Lived
AD Berman 1987 F/60 AVR 10 years AscAo-RA Aortic 
dissection
Surgical Lived
A Caruso 2000 M/41 AVR 8 years AscAo-LA Aortic 
dissection
Surgical Lived
B Bell 2010 M/65 PCI + CABG 25 years;  
19 years
AscAo-RA SVG aneurysm Percutaneous Died
T Sugimoto 2006 M/65 CABG 20 years AscAo-RA SVG aneurysm Surgical Lived
R Benham 1992 M/21 None N/A AscAo-LA Endocarditis Surgical Lived
AJ Page 1973 M/60 None N/A AscAo-RA Aortic 
dissection
Surgical Lived
JH Kay 1959 F/39 Exploration 
through left 
posterolateral 
thoracotomy due 
to cardiac mass
2 months AscAo-LA Aortic 
dissection
Surgical Lived
A Ebringer 1969 F/21 None N/A AscAo-LA Endocarditis No procedure 
performed
Died
EJ Hickey 2008 M/72 CABG 8 years AscAo-RA SVG aneurysm Surgical Lived
U Filizcan 2011 M/62 None N/A AscAo-RA RCA aneurysm Surgical Lived
AC Henze 1991 M/48 AVR 3 years AscAo-RA Aortic 
dissection
Surgical Lived
JS Oliveira 1991 F/37 None N/A AscAo-LA Aortic 
dissection
Patient died 
before surgery
Died
Table 1 (continued)
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Table 1 (continued)
Reference
Year 
published
Sex/age 
(years)
Previous surgery
Time between 
surgery and 
AAF
Type of 
AAF
Cause of AAF
Closure 
technique
Follow-up/
outcome
A Kalangos 2000 M/18 None N/A AscAo-RA Congenital Surgical Not 
described
M/7 None N/A AscAo-RA Congenital Surgical Not 
described
C Türkay 2003 M/29 None N/A AscAo-RA Congenital Surgical Not 
described
PR James 2002 M/34 AVR 1 week AscAo-RA Prosthetic valve 
endocarditis
Surgical Lived
PA Crean 1983 F/65 None N/A AscAo-RA Rheumatoid 
arthritis
Patient died 
before surgery
Died
W Beck 1964 M/42 None N/A AscAo-LA Aneurysm Surgical Lived
JR Büchler 1983 M/53 CABG 2 years AscAo-RA Aortic 
dissection
Surgical Died
W Knirsch 2005 M/3 Percutaneous 
closure of ASD 
4 weeks AscAo-LA ASD device 
closure
Surgical Lived
CS Krishna 2010 F/11 None N/A AscAo-RA Congenital Surgical Lived
M/24 None N/A AscAo-RA Congenital Surgical Lived
YC Tsai 2002 F/2 None N/A AscAo-RA Not described Surgical Lived
AM Esen 2003 M/44 None N/A AscAo-LA Endocarditis Surgical Lived
H Nakano 2000 M/65 AVR 15 years AscAo-RA Aortic 
dissection
Surgical Lived
M Dulake 1964 M/49 None N/A AscAo-RA Aortic 
dissection
Conservative 
medical 
treatment
Died
AD Timmis 1985 M/72 None N/A AscAo-RA Aortic 
dissection
Surgical Died
D Vaidiyanathan 1990 M/30 None N/A AscAo-RA Aortic 
dissection
Conservative 
medical 
treatment
Lived
P Nicod 1984 F/52 CABG 9 years AscAo-RA Aortic 
dissection
Surgical Not 
described
P Nihoyannopoulos 1987 M/4 None N/A DescAo-
LA
Congenital Surgical Lived
S Chandra 2011 F/12 None N/A AscAo-RA Congenital Percutaneous Lived
A Schwartzbard 1998 F/75 AVR 2 years AscAo-LA Prosthetic valve 
endocarditis
Surgical Died
T Feldman 2006 F/76 MVR 10 years AscAo-LA Complication of 
cardiac surgery
Percutaneous Lived
DS Chun 2003 M/10 Percutaneous 
closure of ASD
3 months AscAo-RA ASD device 
closure
Surgical Lived
Table 1 (continued)
7Journal of Thoracic Disease, 2019
© Journal of Thoracic Disease. All rights reserved.   J Thorac Dis 2019jtd.amegroups.com
Table 1 (continued)
Reference
Year 
published
Sex/age 
(years)
Previous surgery
Time between 
surgery and 
AAF
Type of 
AAF
Cause of AAF
Closure 
technique
Follow-up/
outcome
PA Grayburn 2005 F/41 Percutaneous 
closure of ASD
20 months AscAo-RA ASD device 
closure
Surgical Lived
VS Mahadevan 2006 F/17 Percutaneous 
closure of ASD
25 months AscAo-LA ASD device 
closure
Percutaneous Lived
DM Mello 2005 F/16 Percutaneous 
closure of ASD
6 months AscAo-LA ASD device 
closure
Surgical Lived
D Danilowicz 1989 F/5 
days
None N/A AscAo-RA Congenital Surgical Lived
JW Jukema 1992 F/68 CABG 8 years AscAo-RA SVG aneurysm Surgical Lived
C Nathaniel 1996 M/59 CABG 16 years AscAo-RA SVG aneurysm Surgical Died
L Gruberg 1999 M/52 AVR + CABG 17 years AscAo-RA SVG aneurysm Surgical Lived
W Fares 2003 M/73 CABG, dual 
chamber 
pacemaker 
placement
21 years;  
9 years
AscAo-RA SVG aneurysm Percutaneous Lived
SA Photiou 1981 M/55 AVR 10 months AscAo-RA Aneurysm Surgical Lived
A DeSa'Neto 1979 M/17 None N/A AscAo-RA Trauma Surgical Lived
F Moraes 2004 M/1 None N/A AscAo-RA Congenital Surgical Lived
AE Weyman 1975 M/24 None N/A AscAo-RA Aneurysm Surgical Lived
M Aiba 2013 M/71 CABG, Graft 
replacements 
of abdominal 
aorta, bilateral 
femoral + 
popliteal arteries, 
descending aorta
20 years;  
16 years;  
7 years;  
3 years
AscAo-RA SVG aneurysm Surgical Lived
M Yuce 2011 M/70 CABG + 
cardioverter-
defibrillator 
implantation
22 years;  
7 years
AscAo-RA SVG aneurysm Patient 
refused 
surgery
Not 
described
MP Richardson 1992 M/74 CABG 11 years AscAo-RA SVG aneurysm Surgical Died
H Le Breton 1998 M/62 CABG 21 years AscAo-RA SVG aneurysm Surgical Lived
ML Williams 2004 M/58 CABG 12 years AscAo-LA SVG aneurysm Surgical Lived
HD Danenberg 1995 F/49 Percutaneous 
transjugular stent 
placement to IVC 
and left hepatic 
vein
14 months AscAo-RA Complication 
of internal 
jugular vein 
catheterization
Surgical Lived
SK Aggarwal 2007 F/12 None N/A AscAo-RA Congenital Surgical Lived
M/33 None N/A AscAo-RA Aneurysm Surgical Lived
Table 1 (continued)
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Table 1 (continued)
Reference
Year 
published
Sex/age 
(years)
Previous surgery
Time between 
surgery and 
AAF
Type of 
AAF
Cause of AAF
Closure 
technique
Follow-up/
outcome
K Nandate 2016 M/19 None N/A AscAo-LA Trauma Surgical Lived
E Valero 2016 F/60 Ascending aorta 
reconstruction 
without AVR
8 years AscAo-LA Endocarditis Surgical Lived
M Alkouli 2017 M/84 AVR 3 days AscAo-RA Complication of 
cardiac surgery
Percutaneous Lived
T Ahmad 2014 M/71 None N/A AscAo-LA Complication of 
cardiac surgery
Surgical Lived
ES John 2014 F/21 None N/A AscAo-RA Endocarditis Surgical Lived
S Chandra 2013 M/20 None N/A AscAo-LA Endocarditis Surgical Lived
AM Noyes 2015 M/35 None N/A AscAo-LA Endocarditis Surgical Lived
M Bashir 2014 M/27 Percutaneous 
closure of ASD
6 weeks AscAo-RA ASD device 
closure
Surgical Lived
P Sytnik 2015 M/63 Ascending aorta 
reconstruction 
without AVR
9 days AscAo-RA Aortic 
dissection
Surgical Lived
PA Villablanca 2014 F/51 None N/A AscAo-RA Endocarditis Patient 
refused 
surgery
Lived
M Yesin 2015 F/41 MVP + MVR 4 months AscAo-LA Complication of 
cardiac surgery
Surgical Lived
N Raut 2016 M/48 MVR 4 years AscAo-LA Complication of 
cardiac surgery
Surgical Lived
Y Agrawal 2016 M/57 None N/A AscAo-LA Endocarditis Patient died 
before surgery
Died
A Ikeda 2016 M/45 None N/A AscAo-RA Endocarditis Surgical Lived
F Sabzi 2015 F/37 None N/A AscAo-LA 
+ AscAo-
RA
Endocarditis Surgical Lived
L Frey 2014 F/45 None N/A AscAo-RA Endocarditis Surgical Lived
I Ece 2015 F/7 None N/A AscAo-RA Congenital Percutaneous Lived
H Matsumoto 2014 F/72 AVR 3 years AscAo-RA Complication of 
cardiac surgery
Surgical Lived
C Siebers 2014 M/62 AVR 5 years AscAo-RA Prosthetic valve 
endocarditis
Surgical Lived
AC Aykan 2013 M/21 AVR + MVR Not described AscAo-LA Prosthetic valve 
endocarditis
Surgical Lived
MY Tsang 2014 F/43 Multiple catheter 
ablations
Not described AscAo-RA Complication of 
percutaneous 
catheterization
Surgical Not 
described
Table 1 (continued)
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Table 1 (continued)
Reference
Year 
published
Sex/age 
(years)
Previous surgery
Time between 
surgery and 
AAF
Type of 
AAF
Cause of AAF
Closure 
technique
Follow-up/
outcome
A Gunarathne 2013 M/28 None N/A AscAo-RA 
+ AscAo 
RV
Endocarditis Surgical Lived
E Sener 2014 F/19 None N/A AscAo-RA Aneurysm Surgical Lived
R Pancas 2012 F/51 None N/A AscAo-RA Not described Surgical Not 
described
V Patel 2010 F/72 2x AVR 10 years, 
several weeks
AscAo-RA 
+ AscAo 
RV
Complication of 
cardiac surgery
Patient died 
before surgery
Died
T Takamura 2009 F/82 AVR 6 months AscAo-RA Prosthetic valve 
endocarditis
Surgical Lived
MM El Yaman 2007 M/32 Coarctation 
repair, MVR, 
MVR, AVR+MVR
early 
childhood,  
29 years,  
25 years,  
15 years
AscAo-LA Complication of 
cardiac surgery
Percutaneous Lived
O Badak 2003 F/49 AVR + MVR 10 months AscAo-RA Complication of 
cardiac surgery
Surgical Lived
M Hachida 1994 F/57 AVR + MVR + 
Manouguian 
procedure
6 years AscAo-LA Complication of 
cardiac surgery
Surgical Lived
F/49 AVR + MVR + 
Manouguian 
procedure
3 years AscAo-LA 
+ AscAo-
LV
Complication of 
cardiac surgery
Surgical Lived
NE Liddell 1992 M/51 AVR + Aortic root 
replacement
8 weeks AscAo-LA Complication of 
cardiac surgery
Surgical Lived
H Chang 1989 M/25 None N/A AscAo-RA Trauma Surgical Lived
R Hayward 1988 F/72 Ascending aorta 
reconstruction 
without AVR
5 weeks AscAo-RA Complication of 
cardiac surgery
Percutaneous Lived
JL Taylor 1982 M/61 None N/A AscAo-RA Aortic 
dissection
Surgical Lived
R Berkowitz 1973 M/24 Emergency 
thoracotomy 
and suturing of 
laceration RA 
appendage and 
RV
33 days AscAo-RA Trauma Surgical Lived
JS Ladowski 1984 F/56 Closed mitral 
commissurotomy
25 years AscAo-RA Complication of 
percutaneous 
catheterization
Surgical Lived
AAF, aorto-atrial fistula; AscAo, ascending aorta; DescAo, descending aorta; RA, right atrium; LA, left atrium; RV, right ventricle; AVR, 
aortic valve replacement; MVR, mitral valve replacement; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting; 
SVG, saphenous vain graft; IVC, inferior vena cava; ASD, atrial septal defect; RFA, radiofrequency ablation; TIPS, transjugular intrahepatic 
portosystemic shunt. 
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stemmed from India (11 cases), Japan (12 cases) and Turkey 
(12 cases). From the 136 cases analysed the occurrence of 
AAF had a male to female ratio of approximately 2:1. The 
age of the patients in the case reports described ranged 
between 5 days and 85 years old (median 51 years, average 
46 years) (Figure 2B).
Imaging
In 130 out of the 136 cases information was provided 
regarding use of preoperative imaging techniques. In 
the majority of the cases where imaging was utilised, 
echocardiography (83.1%) and angiography (59.6%) 
were favoured (Tables 2 and 3). Out of the 113 reported 
cases where echocardiography was used, the use of 
transthoracic (23.9%) as well as transesophageal (24.8%) 
or the combination of both (23.0%) seemed to be equally 
distributed, whilst in 28.3% of cases the technique the 
authors had used was not specified (Table 3).
Anatomy 
Fistula formation from the ascending aorta to the atria 
occurred more often into the right atrium (86 of the 136 
Figure 2 Demographics of Patient Population with AAF. (A) Number of articles published about AAF in time; (B) occurrence of AAF per 
age group. AAF, aorto-atrial fistula.
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Table 2 Pre-operative diagnostic tests, number of cases, all cases (136)
Pre-operative diagnostic tests (N=136) Number of cases Percentage
Echocardiography only 47 34.6
Echocardiography + Angio 34 25.0
Echocardiography + Angio + CT scan 20 14.7
Echocardiography + Angio + CT-scan + MRI 1 0.7
Echocardiography + Angio + MRI 2 1.5
Echocardiography + CT-scan 8 5.9
Echocardiography + CT-scan + MRI 1 0.7
Angio only 11 8.1
Angio + CT-scan 3 2.2
Angio + MRI 1 0.7
CT-scan only 2 1.5
None described 6 4.4
cases) compared to the left atrium (41 of the 136 cases), at 
a LA to RA ratio of 1:2.1. In two patients, the fistula tract 
originated from the descending aorta into the left atrium 
(DescAo-LA) (1,2). Some very rare cases included fistula 
formation from the descending aorta into the right atrium 
(DescAo-RA) (3), fistula formation to both the left and right 
atrium (4,5) and fistula formation between the ascending 
aorta, right atrium as well as the right ventricle (6-8) and 
fistula formation between the ascending aorta, left atrium as 
well as the left ventricle (9) (Figures 3,4 and Table 4). 
Causes
In the majority of cases (22.8%) endocarditis was the cause 
of AAF formation. In 71% of these cases, a paravalvular 
abscess was also present. Furthermore, 45.2% of these 
patients had prior surgery with a prosthetic valve. Aortic 
aneurysms (22.1%), mainly complicated with dissected 
aortic walls, were the 2nd most common cause. Congenital 
causes (11.8%) were also responsible for a number of AAFs. 
In this group 81.2% of the fistula tracts were from the 
Table 3 Preoperative diagnostic tests, percentages, all cases (136)
Preoperative diagnostic tests (N=136) Number of cases Percentage
Echocardiography 113 83.1
TTE 27 19.9 (23.9% of 113 cases)
TEE 28 20.6 (24.8% of 113 cases)
TTE + TEE 26 19.1 (23.0% of 113 cases)
Type of echocardiography not specified 32  23.5 (28.3% of 113 cases)
Angio 81 59.6
CT-scan 35 25.7
MRI 5 3.7
Not described 6 4.4
TTE, transthoracic echocardiography; TEE, transesophageal echocardiography.
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aorta to the right atrium whilst only 18.8% led into the left 
atrium. Interestingly, chest traumas were a relatively rare 
cause of AAF, with this being the cause in just 3.7% of all 
cases reported. 
In 15.4% of the cases fistula formation occurred 
secondary to cardiac surgery. Saphenous vein graft (SVG) 
aneurysms after coronary artery bypass surgery were 
responsible for 9.6% of the AAF formations in the reported 
cases. Furthermore, in 7.4% of the cases a previous atrial 
septal defect closure with a device was responsible for AAF 
(Table 5).
Therapy
As shown in Table 6, AAF was corrected via an open surgical 
approach in 73.5% of all cases. In 10.3% the fistula was 
closed via a percutaneous intervention, whilst in 4.4% of 
cases a conservative medical approach was advocated (e.g., 
diuretics and blood transfusions), due to the high surgical 
risk. In one case the patient was scheduled for surgical 
closure of the fistula, but echocardiography showed a 
spontaneous closure. In 3.6% of cases the patient refused 
corrective surgery and in 5.1% of all cases the patient 
died before surgery could go ahead. In 1.5% of all cases 
with AAF there was no procedure or medical intervention 
performed, either due to a very high operational risk or 
due to the fact that the fistula had no hemodynamic effects. 
In 0.7% of the cases the treatment of the AAF was not 
described. In 42% of the cases where a surgical approach 
was utilized, the fistula was closed with sutures. In 20% 
of the cases it was opted to close the fistula with a patch, 
whilst in 4% the tract was ligated. A combined approach 
of suturing and the use of patches occurred in 5% of cases. 
The closing technique during corrective surgery was not 
described in 29% of cases (Table 6). When percutaneous 
closure of the fistula tract was employed, closure with an 
Figure 4 A Schematic outline illustrating the occurrence rates of 
different types of AAF. AAF, aorto-atrial fistula.
63.2% AscAo-RA
30.1% AscAo-LA
0.7% DescAo-RA
1.5% DescAo-LA
1.5% AscAo-LA + AscAo-Ra
2.2% AscAo-RA + AscAo-RV
0.7% AscAo-LA + AscAo-LV
Table 4 Type of AAF, all cases (136)
Type of AAF (N=136) Number of cases Percentage
AscAo-RA 86 63.2
AscAo-LA 41 30.1
DescAo-RA 1 0.7
DescAo-LA 2 1.5
AscAo-LA + AscAo-RA 2 1.5
AscAo-RA + AscAo-RV 3 2.2
AscAo LA + AscAo LV 1 0.7
AAF, aorto-atrial fistula; AscAo, ascending aorta; DescAo, 
descending aorta; RA, right atrium; LA, left atrium; RV, right 
ventricle; LV, left ventricle.
Figure 3 Types of AAF. AAF, aorto-atrial fistula.
13Journal of Thoracic Disease, 2019
© Journal of Thoracic Disease. All rights reserved.   J Thorac Dis 2019jtd.amegroups.com
Table 5 Causes of AAF, all cases (136)
Cause of AAF (N=136) Number of cases Percentage Sub-analysis individual groups
Aneurysm 30 22.1 N=30
With dissection 22 16.2 73%
Without dissection 8 5.9 27%
Endocarditis (total) 31 22.8 N=31
With abscess formation 22 16.2 71%
Without abscess formation 9 6.6 29%
Endocarditis no artificial valves 17 12.5 54.8%
With abscess formation 11 8.1 64.7%
Without abscess formation 6 4.4 35.3%
Prosthetic valve endocarditis 14 10.3 45.2%
With abscess formation 11 8.1 78.6%
Without abscess formation 3 2.2 21.4%
Congenital 16 11.8 N=16
Congenital ARAF 13 9.6 81.2%
Congenital ALAF 3 2.2 18.8%
SVG aneurysm 13 9.6 –
Complication of cardiac surgery 21 15.4 –
ASD device closure 10 7.4 –
Chest trauma 5 3.7 –
Stent protuding RA 2 1.5 –
Complication of percutaneous catheterization 3 2.2 –
RCA aneurysm 1 0.7 –
Behcet’s disease 1 0.7 –
Rheumotoid arthritis 1 0.7 –
Accidental finding 1 0.7 –
AAF, aorto-atrial fistula; ARAF, aorto-right atrial fistula; ALAF, aorto-left atrial fistula; SVG, saphenous vein graft; ASD, atrial septal defect; 
RA, right atrium.
Amplatzer device was the treatment of choice (71.4%), 
followed by coil embolization (14.3%), covered stents 
(7.15%) and finally balloon closures (7.15%) (Table 6).
Outcomes
In 74.3% of all studied cases the fistula repair was successful 
and patients survived the procedures. In 14.7% of the cases 
patients did not survive, whilst in 11.0% of the reported 
cases patient’s outcome was not mentioned. In 83% of all 
surgical cases the fistula repair was successful and patients 
survived the procedures. In 85.7% of all the percutaneous 
fistula corrections, the repair was successful and patients 
survived the procedures (Table 7). 
Discussion
We systematically reviewed the literature for reports on 
AAF. We did not identify any reports on systematic registries 
or clinical trials investigating AAF. All our knowledge on 
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Table 6 Treatment of AAF, all cases (136)
Type of treatment (N=136) Number of cases Percentage Sub-analysis individual groups
Surgical closure 100 73.5 N=100
Suture closure of fistula 42 30.9 42% 
Patch closure of fistula 20 14.7 20% 
Combination of suture and patch 5 3.7 5%
Ligation of fistula 4 2.9   4% 
Closing technique not described 29 21.3 29% 
Percutaneous closure 14 10.3 N=14
Amplatzer device 10 7.4 71.4%
Coil embolisation 2 1.5 14.3%
Covered stents 1 0.7 7.15%
Balloon closure 1 0.7 7.15%
Conservative medical treatment 6 4.4 –
Patient died before surgery 7 5.1 –
Patient refused surgery 5 3.7 –
No procedure performed 2 1.5 –
Procedure not described 1 0.7 –
Spontaneous closure 1 0.7 –
AAF, aorto-atrial fistula. 
AFF is therefore currently based on case-reports. Based on 
the reported case reports, we conclude that:
(I) Small AAFs can be asymptomatic and may be 
conservatively approached with the reduction of 
cardiac afterload and the use of diuretics. In these 
cases, it is highly recommended to closely observe 
the patient over time and if clinical conditions 
deteriorate, active closure of the fistula should be 
considered. 
(II) Large AAFs require immediate closure either 
percutaneously or via a surgical approach. 
Spontaneous closure of an AAF is very rare and 
conservative treatment must be strongly discouraged 
in cases with large fistulas or clinical symptoms 
ensue.
(III) Although the case volume is low, compared to 
surgery, percutaneous closure has shown comparable 
outcome. 
The surgical approach to close the fistula often entails 
suturing or the use of a patch. Percutaneous closure of AAF 
has been employed more often in the last few years. There 
are no specific devices for transcatheter closure of fistulas, 
but devices like the Amplatzer Septal Occluder, used for 
closing atrial septal defects, have proven their applicability 
for this purpose. Overall treatment success rates are at least 
70% with a mortality rate of around 15%. 
There are a number of limitations to our study, with 
the major limitation being that reported data came from 
case reports or case series. For these reasons, it is likely 
that there is some publication bias as it is highly likely that 
not all cases have been published. Furthermore, cases of 
patients who were unsuccessfully treated are less likely to be 
reported. Data from larger populations is lacking, meaning 
that specific data regarding incidence and prevalence does 
currently not exist. This review provides us with a number 
of insights into the occurrence and pathophysiology of AAF, 
as well as the current treatment options for this rare, but 
potentially life threatening, condition.
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Table 7 Outcome of AAF, all cases (136)
Type of treatment (N=136) Survived Died Not described Number of cases
Intervention
Surgical closure 83 (83%) 7 (7%) 10 (10%) N=100
Suture closure 37 (88.1%) 1 (2.4%) 4 (9.5%) N=42
Patch closure 16 (80%) 2 (10%) 2 (10%) N=20
Suture and patch closure 5 (100%) – – N=5 
Ligation 4 (100%) – – N=4
Closing technique not described 21 (72.4%) 4 (13.8%) 4 (13.8%) N=29
Percutaneous closure 12 (85.7%) 1 (7.1%) 1 (7.1%) N=14
Amplatzer device 9 (90%) – 1 (10%) N=10
Coil embolization 2 (100%) – – N=2
Covered stents – 1 (100%) – N=1
Balloon closure 1 (100%) – – N=1
Procedure not described – – 1 (100%) N=1
Overall treatment success 95 (82.6%) 8 (7.0%) 12 (10.4%) N=115
No intervention
Conservative medical treatment 3 (50%) 3 (50%) – N=6
No procedure performed 1 (50%) 1 (50%) – N=2
Patient refused surgery 1 (20%) 1 (20%) 3 (60%) N=5
Spontaneous closure 1 (100%) – – N=1
Patient died before surgery – 7 (100%) – N=7
Overall 101 (74.3%) 20 (14.7%) 15 (11.0%) N=136
AAF, aorto-atrial fistula.
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